Insider Transactions in Q1 2022 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
718
-2.05%
|
$30,156
$42.55 P/Share
|
|
Feb 21
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+4.67%
|
-
|
|
Feb 21
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-0.28%
|
$19,236
$42.55 P/Share
|
|
Feb 21
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,558
+0.94%
|
-
|
|
Feb 21
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
275
-1.09%
|
$11,550
$42.55 P/Share
|
|
Feb 21
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
935
+3.56%
|
-
|
|
Feb 21
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,923
-0.88%
|
$80,766
$42.55 P/Share
|
|
Feb 21
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+1.76%
|
-
|
|
Feb 21
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,209
-2.29%
|
$50,778
$42.55 P/Share
|
|
Feb 21
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,726
+4.91%
|
-
|
|
Feb 21
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,462
-0.35%
|
$313,404
$42.55 P/Share
|
|
Feb 21
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,825
+0.78%
|
-
|
|
Feb 21
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-0.87%
|
$12,516
$42.55 P/Share
|
|
Feb 21
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,013
+2.87%
|
-
|
|
Feb 21
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
859
-0.61%
|
$36,078
$42.55 P/Share
|
|
Feb 21
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,804
+1.94%
|
-
|
|
Feb 21
2022
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.58%
|
$7,560
$42.55 P/Share
|
|
Feb 21
2022
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
623
+1.98%
|
-
|
|
Feb 21
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-0.34%
|
$24,906
$42.55 P/Share
|
|
Feb 21
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+0.96%
|
-
|
|
Feb 21
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
732
-16.72%
|
$30,744
$42.55 P/Share
|
|
Feb 21
2022
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,493
+36.29%
|
-
|
|
Feb 21
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
606
-4.0%
|
$25,452
$42.55 P/Share
|
|
Feb 21
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+6.71%
|
-
|
|
Feb 21
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-1.02%
|
$9,618
$42.55 P/Share
|
|
Feb 21
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
779
+3.34%
|
-
|
|
Feb 21
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.91%
|
$14,028
$42.55 P/Share
|
|
Feb 21
2022
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+2.9%
|
-
|
|
Feb 21
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
964
-1.03%
|
$40,488
$42.55 P/Share
|
|
Feb 21
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+1.8%
|
-
|
|
Feb 18
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,644
-0.6%
|
$69,048
$42.55 P/Share
|
|
Feb 18
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.34%
|
-
|
|
Feb 18
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-0.68%
|
$8,988
$42.55 P/Share
|
|
Feb 18
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
741
+2.28%
|
-
|
|
Feb 18
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
992
-2.9%
|
$41,664
$42.55 P/Share
|
|
Feb 18
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,372
+6.48%
|
-
|
|
Feb 18
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
544
-0.33%
|
$22,848
$42.55 P/Share
|
|
Feb 18
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+1.12%
|
-
|
|
Feb 18
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-1.32%
|
$13,734
$42.55 P/Share
|
|
Feb 18
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,112
+4.31%
|
-
|
|
Feb 18
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,829
-0.85%
|
$76,818
$42.55 P/Share
|
|
Feb 18
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.69%
|
-
|
|
Feb 18
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
10,310
-17.08%
|
$433,020
$42.55 P/Share
|
|
Feb 18
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
25,942
+16.26%
|
-
|
|
Feb 18
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,233
-0.34%
|
$303,786
$42.55 P/Share
|
|
Feb 18
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,307
+0.76%
|
-
|
|
Feb 18
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-0.91%
|
$12,810
$42.55 P/Share
|
|
Feb 18
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,037
+3.0%
|
-
|
|
Feb 18
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.62%
|
$36,204
$42.55 P/Share
|
|
Feb 18
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,816
+1.98%
|
-
|